Skip to main content

Table 1 Clinical features of the assessed COVID-19 infected cancer patients

From: The annual conference of National Cancer Institute - Cairo University "Bridging Gaps in Oncology"

 Variables

Frequency

Percent (%)

Patients

Paediatric

15

30.6

Adult

34

69.4

Age

Paediatric (mean±SEM)

7.6±1.39

Median (range)

7.5 (1-17)

Adult (mean±SEM)

51.3±2

Median (range)

52 (23-67)

Gender

Male

27

55.1

Female

22

44.9

Comorbidities

Diabetes mellitus

11

22.4

Cardiac disease

12

24.5

Renal disease

12

24.5

Type of malignancy

AML

13

26.5

ALL

9

18.4

Lymphoma

8

16.3

HCC

1

2.0

Synovial Sarcoma

1

2.0

Breast cancer

3

6.1

CRC

3

6.1

Squamous cell carcinoma

1

2.0

Multiple myeloma

1

2.0

Cholangiocarcinoma

1

2.0

Neuroblastoma

1

2.0

Thyroid

1

2.0

Urinary bladder cancer

3

6.1

Ewing sarcoma

1

2.0

Renal cell carcinoma

1

2.0

Wilms tumour

1

2.0

Disease state

Disease progression

26

53.1

Remission or responding

19

38.8

Stationary

4

8.1

Clinical FEVER

No

6

12.2

Yes

43

87.8

GIT

No

19

38.8

Yes

30

61.2

Chest symptoms

No

2

4.1

Yes

41

83.7

NA

6

12.2

Bony Pains

No

39

79.6

Yes

10

20.4

Loss of weight

No

42

85.7

Yes

7

14.3

Loss of smell

No

44

89.8

Yes

5

10.2

Sore throat

No

47

95.9

Yes

2

4.1

Dialysis

Yes

2

4.1

NA

47

95.9